Refurbished Medical Imaging Devices Market Size - Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Refurbished medical imaging devices are diagnostic imaging systems that have been previously used and then professionally restored, through inspection, repair, replacement of worn components, recalibration, and software updates, to meet original manufacturer performance specifications before re-entering the clinical market. The global market reached an estimated $4.4 billion in 2023 and is tracking toward approximately $6.034 billion in 2026, with forecasts extending to $8.7 billion by 2030 at a CAGR near 9.7%, though projection methodologies vary across research firms depending on whether they include only certified refurbished units or also grey-market resales. Refurbished equipment serves a distinct and growing niche between new-system procurement, often requiring capital expenditures in the hundreds of thousands to millions of dollars per unit, and decommissioned equipment resale, appealing to small and mid-sized hospitals, outpatient imaging centers, diagnostic laboratories, and emerging-market health systems.

• •Market valued at ~$4.4B in 2023, ~$6.034B in 2026, with projections to $8.7B by 2030 at ~9.7-10.4% CAGR depending on source methodology
• •Covers professionally restored MRI, CT, X-ray, ultrasound, nuclear medicine, and mammography systems resold to clinical providers
• •Serves hospitals, imaging centers, clinics, and emerging-market health systems seeking lower-cost access to advanced diagnostic capability

Sustained cost pressures on hospital capital expenditure budgets are the single largest driver of refurbished imaging adoption, as providers face reimbursement compression and seek to maximize return on existing infrastructure investments without compromising diagnostic quality. Original equipment manufacturer trade-in and certified refurbishment programs have helped legitimize the category by offering manufacturer-backed warranties and service agreements that reduce perceived risk for procurement officers. Meanwhile, rising global demand for diagnostic imaging services, driven by aging populations, increasing prevalence of chronic diseases such as cancer and cardiovascular conditions, and expanding screening programs, is creating volume demand that new-system supply chains cannot fully satisfy in cost-sensitive markets.

• •OEM-certified refurbishment programs with manufacturer warranties have reduced buyer risk and expanded institutional acceptance
• •Healthcare cost containment and value-based care models incentivize providers to extend equipment life cycles and lower per-study costs
• •Rising global diagnostic imaging volume driven by aging demographics, chronic disease burden, and expanding screening programs outstrips new-system supply in price-sensitive regions

The market is commonly segmented by product modality, with MRI systems, computed tomography (CT) scanners, X-ray equipment, and ultrasound machines representing the largest refurbished categories, weighted by both installed base and replacement cycle, and by end user, including hospitals, diagnostic imaging centers, ambulatory surgical centers, and academic and research institutions. Geographically, North America currently holds the largest share, supported by a high density of installed imaging systems entering replacement cycles, a robust OEM-certified refurbishment infrastructure, and a regulated reimbursement environment that rewards cost-efficient care delivery. Europe follows as a significant market with comparable dynamics, while Asia-Pacific is emerging as the fastest-growing regional segment, driven by India, China, and Southeast Asian nations building out healthcare infrastructure through cost-effective refurbished equipment imports.

• •Modality segments include MRI, CT, X-ray, ultrasound, mammography, and nuclear imaging, with MRI and CT representing premium refurbished categories commanding the highest unit values
• •North America leads in market share due to high installed-base turnover, OEM refurbishment programs, and regulated cost-containment mandates
• •Asia-Pacific is the fastest-growing region as developing health systems adopt refurbished equipment to expand diagnostic capacity at lower capital cost

Who are the notable companies in the industry?

The market is moderately fragmented, with a competitive structure that spans three overlapping tiers: original equipment manufacturers operating certified pre-owned or certified refurbished programs with full warranty and service backing; independent specialty refurbishers that acquire decommissioned systems from hospitals and OEMs, restore them to specification, and resell with varying warranty coverage; and regional broker and dealer networks that facilitate secondary-market transactions, particularly in markets with less developed certified-refurbishment infrastructure. OEM-affiliated channels tend to dominate premium-segment transactions where regulatory compliance and service continuity are paramount, while independent refurbishers capture price-sensitive buyers and serve emerging markets where OEM-certified supply is limited. Regional capacity concentration follows healthcare infrastructure density, with North America and Western Europe hosting the majority of established refurbishment facilities, and Asia-Pacific capacity expanding as local refurbishment ecosystems develop to serve domestic and intra-regional demand.

• •Market is moderately fragmented across OEM-certified programs, independent specialty refurbishers, and regional broker/dealer networks, each serving distinct buyer segments and price tiers
• •OEM-certified channels command premium pricing and serve regulated institutional buyers; independent refurbishers compete on cost and serve price-sensitive and emerging-market buyers
• •Refurbishment capacity is concentrated in North America and Western Europe, with growing activity in Asia-Pacific as regional healthcare infrastructure investment accelerates

What are the recent trends and outlook?

Looking forward, the market is expected to maintain a compound annual growth rate near 9-10% through 2030, supported by the convergence of aging diagnostic infrastructure in mature markets, healthcare digitization efforts that lower the operational cost of managing refurbished equipment through cloud-based service platforms, and increasing regulatory acceptance of certified pre-owned medical devices. A notable trend is the extension of OEM full-service management programs to cover refurbished fleets, blurring the historical line between new and refurbished procurement and making refurbished equipment a more seamless component of multi-year equipment lifecycle strategies. Sustainability and circular-economy framing are also gaining traction as health systems and OEMs alike face pressure to demonstrate responsible resource stewardship through equipment reuse and life-extension initiatives.

• •Long-term growth sustained by aging installed bases entering replacement cycles in both developed and emerging markets
• •OEM full-service and managed-equipment programs expanding to cover refurbished fleets, reducing the distinction between new and refurbished procurement in buyer decision-making
• •Sustainability and circular-economy narratives gaining influence as healthcare organizations incorporate equipment life-extension into environmental and cost-reduction strategies